Solvay to promote SmithKline Beecham's Famvir to OB-GYNs.
Executive Summary
SOLVAY TO CO-PROMOTE SMITHKLINE BEECHAM FAMVIR TO OB-GYNs WITH 330 REPS, integrating calls for Famvir (famciclovir) into its promotions for women's health. "Our commitment to women's health, our ability to drive market share and our growing experience with alliances and cooperative ventures will be the platform for the success of the co-promotion," Solvay commented.